Professor, Pediatrics, University of Colorado School of Medicine
Pediatric Hematology & Oncology
Dr. Stephen P. Hunger, MD
|
|
Give Review
Stephen P. Hunger practices Pediatric Hematology & Oncology. He went to medical school at University of Connecticut School of Medicine. University of Connecticut School of Medicine has a rank of 60 in research and a 49 in primary care Stephen Hunger is also a published doctor. He has 99 publication published. The most recent publication is: MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: A children's oncology group study.
Publications
- MLL rearrangements impact outcome in HOXA-deregulated T-lineage Acute lymphoblastic leukemia: A children's oncology group study.
- Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma.
- Therapies on the horizon for childhood Acute lymphoblastic leukemia.
- Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia.
- Reply to: Obesity is an important health problem in survivors of pediatric Acute lymphoblastic leukemia.
- Genetic risk factors for the development of osteonecrosis in children under age 10 treated for Acute lymphoblastic leukemia.
- Germline genetic variation in ETV6 and risk of childhood Acute lymphoblastic leukaemia: a systematic genetic study.
- Outcome of Children with Standard-Risk T-Lineage Acute Lymphoblastic Leukemia-Comparison among Different Treatment Strategies.
- Genetics of glucocorticoid-associated osteonecrosis in children with Acute lymphoblastic leukemia.
- Self-Enforcing Feedback Activation between BCL6 and Pre-B Cell Receptor Signaling Defines a Distinct Subtype of Acute Lymphoblastic Leukemia.
- Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic Leukemia.
- Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell Acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434.
- Re-induction chemoimmunotherapy with epratuzumab in relapsed Acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2.
- Signalling thresholds and negative B-cell selection in Acute lymphoblastic leukaemia.
- Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) Acute lymphoblastic leukemia.
- Survivors of standard risk Acute lymphoblastic leukemia do not have increased risk for overweight and obesity compared to non-cancer peers: A report from the Children'...
- Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with Acute lymphoblastic leukemia.
- A genome-wide association study of susceptibility to Acute lymphoblastic leukemia in adolescents and young adults.
- Pharmacokinetic and Pharmacodynamic Properties of Calaspargase Pegol Escherichia coli L-Asparaginase in the Treatment of Patients With Acute Lymphoblastic Leukemia: Re...
- Intensified chemotherapy without SCT in infant ALL: Results from COG P9407 (Cohort 3).
- Decreased induction morbidity and mortality following modification to induction therapy in infants with Acute lymphoblastic leukemia enrolled on AALL0631: A report fro...
- An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element.
- Family life events in the first year of Acute lymphoblastic leukemia therapy: A children's oncology group report.
- Wnt inhibition leads to improved chemosensitivity in paediatric Acute lymphoblastic leukaemia.
- HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies.
- Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive Acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031.
- Philadelphia chromosome-negative very high-risk Acute lymphoblastic leukemia in children and adolescents: results from Children's Oncology Group Study AALL0031.
- A prospective study of anxiety, depression, and behavioral changes in the first year after a diagnosis of childhood Acute lymphoblastic leukemia: A report from the Chi...
- Expanding Clinical Trial Networks in Pediatric Acute Lymphoblastic Leukemia.
- Introduction and overview to issue on new developments in pediatric hematology/oncology.
- Inherited GATA3 variants are associated with Ph-like childhood Acute lymphoblastic leukemia and risk of relapse.
- Mentoring in Pediatric Oncology: A Report from the Children's Oncology Group Young Investigator Committee.
- Intrachromosomal Amplification of Chromosome 21 Is Associated With Inferior Outcomes in Children With Acute Lymphoblastic Leukemia Treated in Contemporary Standard-Ris...
- VPREB1 deletions occur independent of lambda light chain rearrangement in childhood Acute lymphoblastic leukemia.
- Novel Susceptibility Variants at 10p12.31-12.2 for Childhood Acute Lymphoblastic Leukemia in Ethnically Diverse Populations.
- Genome-wide study of methotrexate clearance replicates SLCO1B1.
- Potent obatoclax cytotoxicity and activation of triple death mode killing across infant Acute lymphoblastic leukemia (ALL).
- Relapse-specific mutations in NT5C2 in childhood Acute lymphoblastic leukemia.
- The genomic landscape of hypodiploid Acute lymphoblastic leukemia.
- Tyrosine kinome sequencing of pediatric Acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project.
- Leukemic blasts with the paroxysmal nocturnal hemoglobinuria phenotype in children with Acute lymphoblastic leukemia.
- A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors.
- The thirteenth international childhood Acute lymphoblastic leukemia workshop report: La Jolla, CA, USA, December 7-9, 2011.
- Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with Acute lymphoblastic leukaemia: results fro...
- Recent advances in the understanding and treatment of pediatric Leukemias.
- Blood consult: therapeutic strategy and complications in the adolescent and young adult with Acute lymphoblastic leukemia.
- Gene expression profiles predictive of outcome and age in infant Acute lymphoblastic leukemia: a Children's Oncology Group study.
- Integrated genomic analysis of relapsed childhood Acute lymphoblastic leukemia reveals therapeutic strategies.
- The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell Acute lymphoblastic leukemia.
- Key pathways are frequently mutated in high risk childhood Acute lymphoblastic leukemia: a report from the Children's Oncology Group.
- Improving outcomes for high-risk ALL: translating new discoveries into clinical care.
- Escalating intravenous methotrexate improves event-free survival in children with standard-risk Acute lymphoblastic leukemia: a report from the Children's Oncology Group.
- Acquired growth hormone deficiency in a girl with chronic myelogenous Leukemia treated with tyrosine kinase inhibitor therapy.
- Postrelapse survival in childhood Acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group.
- Ancestry and pharmacogenomics of relapse in Acute lymphoblastic leukemia.
- Augmented therapy improves outcome for pediatric high risk Acute lymphocytic leukemia: Results of Children's Oncology Group trial P9906.
- L-asparaginase treatment in Acute lymphoblastic leukemia: a focus on Erwinia asparaginase.
- Tyrosine kinase inhibitor use in pediatric Philadelphia chromosome-positive Acute lymphoblastic anemia.
- Identification of novel cluster groups in pediatric high-risk B-precursor Acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA...
- Metastatic alveolar rhabdomyoSarcoma in multiple endocrine neoplasia type 2A.
- Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive Acute lymphoblastic leukemia treated between 1995 and 2005.
- Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell Acute lymphoblastic leukemia.
- Down syndrome childhood Acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Childre...
- Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor Acute l...
- Inactivation of LEF1 in T-cell Acute lymphoblastic leukemia.
- Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor Acute ly...
- Acute tumor lysis syndrome in a 7-month-old with hepatoblastoma.
- Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated Acute lymphoblastic leukemia.
- Young adults with Acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the ...
- Improved early event-free survival with imatinib in Philadelphia chromosome-positive Acute lymphoblastic leukemia: a children's oncology group study.
- Phase I and pharmacokinetic study of cetuximab and irinotecan in children with refractory solid tumors: a study of the pediatric oncology experimental therapeutic inve...
- Germline genomic variants associated with childhood Acute lymphoblastic leukemia.
- High frequency of PTEN, PI3K, and AKT abnormalities in T-cell Acute lymphoblastic leukemia.
- JAK mutations in high-risk childhood Acute lymphoblastic leukemia.
- Acute leukemia in adolescents and young adults.
- Treatment strategies and regimens of graduated intensity for childhood Acute lymphoblastic leukemia in low-income countries: A proposal.
- Novel targeted drug therapies for the treatment of childhood Acute leukemia.
- Long-term Disease control of refractory anaplastic large cell lymphoma with vinblastine.
- Genome-wide interrogation of germline genetic variation associated with treatment response in childhood Acute lymphoblastic leukemia.
- Deletion of IKZF1 and prognosis in Acute lymphoblastic leukemia.
- Controversies of and unique issues in hematopoietic cell transplantation for infant Leukemia.
- Factors influencing survival after relapse from Acute lymphoblastic leukemia: a Children's Oncology Group study.
- Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood Acute lymphoblastic leukemia.
- Reinduction platform for children with first marrow relapse of Acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected].
- BAC to the future? comparative genomic hybridization and genotyping pediatric Leukemia cytogenetic abnormalities.
- Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from Acute lymphoblastic leukemia patients.
- Flavopiridol displays preclinical activity in Acute lymphoblastic leukemia.
- Pediatric T-Cell post-transplant lymphoproliferative disorder after solid organ transplantation.
- Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in Acute lymphoblastic leukemia cell lines.
- Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediat...
- Risk- and response-based classification of childhood B-precursor Acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Gr...
- ABCB1 over-expression and drug-efflux in Acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression.
- Biologic pathways associated with relapse in childhood Acute lymphoblastic leukemia: a Children's Oncology Group study.
- Therapy of low-risk subsets of childhood Acute lymphoblastic leukemia: when do we say enough?
- Childhood Leukemia--new advances and challenges.
- Polycythemia vera in a child following treatment for Acute lymphoblastic leukemia.
- Assessment of t(2;5)(p23;q35) translocation and variants in pediatric ALK+ anaplastic large cell Lymphoma.
- Translocation (11;15;19): a highly specific chromosome rearrangement associated with poorly differentiated thymic carcinoma in young patients.
Schools
University Of Connecticut School Of Medicine
Johns Hopkins University Program
Stanford University Program
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Education
-
Stanford University -
Johns Hopkins University -
University of Connecticut School of Medicine
Helpful Reviews
Similar Doctors
|
Dr. Taizo A. Nakano, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachelle F. Nuss, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashley E. Rogers, MD |
|
|
Dr. Brian S. Greffe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roger H. Giller, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Amy K. Keating, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher C. Silliman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer L. Salstrom, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jorge A. Dipaola, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathleen M. Dorris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carrye R. Cost, MD
This Doctor is OpenDoctor Recommended.
|